Akebia Therapeutics, Inc. (AKBA)
1.375
0.00 (0.00%)
USD |
NASDAQ |
Jan 14, 16:00
1.375
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Gross Profit (Annual): 91.34M for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Pfizer Inc. | 41.85B |
| Plus Therapeutics, Inc. | 4.972M |
| Ironwood Pharmaceuticals, Inc. | 349.40M |
| Pyxis Oncology, Inc. | 12.69M |
| Theravance Biopharma, Inc. | 58.37M |